1700008K24Rik Activators comprise a collection of chemical compounds that serve to enhance the functional activity of the protein through various signaling mechanisms. Forskolin and IBMX are key players in raising intracellular cyclic nucleotide levels, which bolster PKA and PKG pathways, known to phosphorylate proteins within the signaling landscape of 1700008K24Rik, facilitating its activity. Similarly, the calcium ionophores Ionomycin and A23187 augment intracellular calcium levels, which is pivotal for the activation of calcium-dependent proteins, thereby indirectly promoting 1700008K24Rik's activity through such signaling conduits. PMA, a potent activator of PKC, and Epigallocatechin gallate, a kinase inhibitor, modulate the phosphorylation states of proteins within the signaling network in which 1700008K24Rik is implicated, potentiating its activity. LY294002and U0126, by targeting PI3K and MEK respectively, modify downstream signaling pathways like AKT/mTOR and MAPK/ERK that are speculated to be relevant for 1700008K24Rik's functionality. This modulation can lead to an indirect enhancement of 1700008K24Rik, accommodating shifts in the signaling equilibrium that favor its activity.
Moreover, the involvement of compounds like SB203580, Genistein, and Wortmannin further exemplifies the diversity of pathways influencing 1700008K24Rik's activation. SB203580's inhibition of p38 MAPK, Genistein's tyrosine kinase inhibition, and Wortmannin's interference with PI3K/AKT signaling collectively contribute to the enhancement of 1700008K24Rik by modulating competitive or complementary signaling processes. Sphingosine-1-phosphate, through its engagement with sphingosine-1-phosphate receptors, introduces a lipid signaling dimension that could intersect with the functional pathways of 1700008K24Rik. These activators, through their targeted biochemical actions, enhance the functional activity of 1700008K24Rik without necessitating an increase in its expression or direct activation, instead facilitating its activity by finely tuning the cellular signaling milieu in which 1700008K24Rik operates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases (PDEs), leading to increased cAMP and cGMP levels in cells. Elevated cAMP/cGMP can enhance the activity of 1700008K24Rik by stimulating PKA and PKG pathways that could interact with the protein's associated signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may indirectly enhance the activity of 1700008K24Rik by modulating phosphorylation states of proteins within its signaling network. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore for calcium, raising intracellular calcium levels and potentially enhancing 1700008K24Rik activity through calcium-dependent signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore, which increases intracellular calcium concentration, indirectly enhancing 1700008K24Rik activity by activating calcium-dependent proteins within its signaling context. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which could enhance 1700008K24Rik activity by triggering downstream signaling events that intersect with the protein's functional pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits various protein kinases, potentially enhancing 1700008K24Rik activity by modulating kinase-driven signaling pathways that the protein may interact with. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, altering downstream signaling that could enhance 1700008K24Rik activity by affecting the AKT/mTOR signaling pathway, which may be involved in the protein's regulatory network. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, potentially enhancing 1700008K24Rik activity by affecting the p38 MAPK signaling cascade, which may be relevant to the protein's functional role. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can enhance 1700008K24Rik activity by inhibiting competitive signaling pathways, thereby modulating the cellular context in which 1700008K24Rik operates. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor, which may enhance 1700008K24Rik activity by altering the PI3K/AKT pathway, a signaling cascade that could intersect with the protein's functional network. | ||||||